News: Press Releases

Press Releases
Kane Biotech Completes Pilot Manufacturing Phase of StrixNB™ Oral Care Product

WINNIPEG, MB. (October 10, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that the Company has successfully developed the manufacturing process…

> Read More

Press Releases
Kane Biotech Announces Extension of Term of Warrants

WINNIPEG, MB. (October 2, 2012) – Kane Biotech Inc. (TSX-V:KNE) (the “Company”), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms announces that it has amended the terms of its 19,926,328 warrants (the “Warrants”)…

> Read More

Press Releases
Kane Biotech and the U.S Army Institute of Surgical Research Sign Cooperative Research and Development Agreement

WINNIPEG, MB. (October 1, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms announces that a Cooperative Research and Development Agreement (CRADA) has just been signed…

> Read More

Press Releases
Kane Biotech Issued New Patent in Japan

WINNIPEG, MB. (September 24, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce the issuance of Patent (No.4999842) entitled “Antimicrobial compositions for…

> Read More

Press Releases
Kane Biotech Commences Veterinary Clinic Testing of StrixNB™ Pet Oral Care Product

WINNIPEG, MB. (September 19, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms announces veterinary clinic testing of the company’s StrixNB pet oral care product is…

> Read More

Press Releases
Kane Biotech Announces Changes to the Board of Directors

WINNIPEG, MB. (September 17, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms announces the appointment of Gord Froehlich to the Company’s Board of Directors and…

> Read More

Press Releases
Kane Biotech Presents Innovation at 2012 Kansas City Animal Health Investment Forum

WINNIPEG, MB. (August 28, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, presents at the fourth annual KC Animal Health Investment Forum today, showcasing its…

> Read More

Press Releases
Kane Biotech Announces Grant of Options and Updates Investor Relations Agreement

WINNIPEG, Manitoba (July 9, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 1,032,500 stock options at…

> Read More

Press Releases
Kane Biotech Announces Board Members

WINNIPEG, Manitoba (July 03, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that the Company’s Annual and Special Meeting of shareholders…

> Read More

Press Releases
Kane Biotech Files PCT Patent on Bone Tissue Regeneration Technology

Highlights:

Research study demonstrates bone regenerating activity Global annual market for bone tissue regeneration is over $32 billion

WINNIPEG, Manitoba (May 30, 2012) – – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products…

> Read More